# The Medicines for Human Use (Clinical Trials) (Amendment) (EU Exit) Regulations 2019, Regulation 14: Amendment of regulation 33 (notification of suspected unexpected serious adverse reactions)

Extent: E+W+S+N.I.

(1) Regulation 33 is amended as follows.
(2) Omit paragraph (1)(b)(ii).
(3) Omit paragraph (3)(b).
(4) Omit paragraph (4).
(5) Omit paragraph (6)(b), and the “and” immediately preceding it.

---
Source: https://www.legislation.gov.uk/uksi/2019/744/regulation/14 (the official version)
Page: https://openlegislation.uk/medicines-for-human-use-clinical-trials-amendment-eu-exit-regulations-2019/regulation-14
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.